Paper Details

Tehran University of Medical Sciences

Science Communicator Platform

Faculty Members have conducted research related to the The Early Versus Standard Administration of Cabergoline to Prevent Ovarian Hyperstimulation Syndrome in Patients With Polycystic Ovary Syndrome Undergoing Icsi Cycles: A Randomized Clinical Trial

Shohreh Movahedi

Assistant Professor of Obstetrics and Gynecology

Department Obstetrics and Gynecology

School of Medicine

Baharlou Hospital

Tehran University of Medical Sciences

Related Documents

1. Outcomes of Assisted Reproduction Treatment After Dopamine Agonist -Cabergoline- for Prevention of Ovarian Hyper Stimulation Syndrome, Medical Journal of the Islamic Republic of Iran (2016)

All Documents

1. Evaluating the Newborn-Related Outcomes of Pregnancy After Covid-19 Sinopharm Vaccination, Archives of Pediatric Infectious Diseases (2025)

2. Xyla-P Cream Vs. Lidocaine Spray: Impact on Patient Satisfaction, Anxiety, Cooperation, and Pain in Spinal Anesthesia for Cesarean Section, Anesthesiology and Pain Medicine (2024)

3. Multilocus Vntr Analysis-Ompa Typing of Chlamydia Trachomatis Isolates in Tehran, Iran, Journal of Infection and Chemotherapy (2023)

4. The Effect of an Mhealth Application Based on Continuous Support and Education on Fear of Childbirth, Self-Efficacy, and Birth Mode in Primiparous Women: A Randomized Controlled Trial, PLoS ONE (2023)

5. Outcomes of Assisted Reproduction Treatment After Dopamine Agonist -Cabergoline- for Prevention of Ovarian Hyper Stimulation Syndrome, Medical Journal of the Islamic Republic of Iran (2016)